News
News
PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials
Pneumonia, one of the diseases caused by pneumococcal bacteria, is currently the leading single killer of young...
PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every...
PnuVax Announces Preclinical In-vivo Pneumococcal Conjugate Vaccine Immunogenicity Results
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every...